Indian pharmaceutical company headquartered in Mumbai, Maharashtra, founded in 1973 and listed on the National Stock Exchange and BSE. Develops, manufactures and markets branded generic and generic medicines with a focus on ophthalmology, dermatology, cardiology and pain management in India, along with anti-malarial and other products for emerging markets in Asia and Africa and generic dosage forms for the United States. Runs manufacturing plants in India and Mauritius approved by the United States FDA and other regulators together with its own research centres.
Aucun commentaire disponible.
Laissez votre note & commentaire